Trial Shows Abeona’s Gene Therapy EB-101 Helps Wounds Heal in RDEB Patients – Epidermolysis Bullosa News
Epidermolysis Bullosa News |
Trial Shows Abeona's Gene Therapy EB-101 Helps Wounds Heal in RDEB Patients
Epidermolysis Bullosa News Results from a Phase 1/2 trial in recessive dystrophic epidermolysis bullosa (RDEB) showed that gene therapy candidate EB-101 led to durable wound healing and improved quality of life, according to Abeona Therapeutics. The updated findings on Abeona's … |
